Activity-Based Protein Profiling Identifies α‑Ketoamides as Inhibitors for Phospholipase A2 Group XVI

• Published in: ACS chemical biology 2019-02, Vol.14 (2), p.164-169
• Main Authors: Zhou, Juan, Mock, Elliot D, Martella, Andrea, Kantae, Vasudev, Di, Xinyu, Burggraaff, Lindsey, Baggelaar, Marc P, Al-Ayed, Karol, Bakker, Alexander, Florea, Bogdan I, Grimm, Sebastian H, den Dulk, Hans, Li, Chun T, Mulder, Laura, Overkleeft, Herman S, Hankemeier, Thomas, van Westen, Gerard J. P, van der Stelt, Mario
• Format: Article
• Language: English
• Subjects: Amides - chemistry; Animals; Enzyme Inhibitors - chemistry; Enzyme Inhibitors - pharmacology; Humans; Letters; Phospholipases A2 - drug effects; Proteins - chemistry
• ISSN: 1554-8929; 1554-8937
• DOI: 10.1021/acschembio.8b00969

Phospholipase A2, group XVI (PLA2G16) is a thiol hydrolase from the HRASLS family that regulates lipolysis in adipose tissue and has been identified as a host factor enabling the cellular entry of picornaviruses. Chemical tools are essential to visualize and control PLA2G16 activity, but they have not been reported to date. Here, we show that MB064, which is a fluorescent lipase probe, also labels recombinant and endogenously expressed PLA2G16. Competitive activity-based protein profiling (ABPP) using MB064 enabled the discovery of α-ketoamides as the first selective PLA2G16 inhibitors. LEI110 was identified as a potent PLA2G16 inhibitor (Ki = 20 nM) that reduces cellular arachidonic acid levels and oleic acid-induced lipolysis in human HepG2 cells. Gel-based ABPP and chemical proteomics showed that LEI110 is a selective pan-inhibitor of the HRASLS family of thiol hydrolases (i.e., PLA2G16, HRASLS2, RARRES3 and iNAT). Molecular dynamic simulations of LEI110 in the reported crystal structure of PLA2G16 provided insight in the potential ligand–protein interactions to explain its binding mode. In conclusion, we have developed the first selective inhibitor that can be used to study the cellular role of PLA2G16.